Chemours
460 hedge funds and large institutions have $846M invested in Chemours in 2015 Q3 according to their latest regulatory filings, with 460 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
71.26% more ownership
Funds ownership: 0% → 71.26% (+71%)
52% less call options, than puts
Call options by funds: $7.66M | Put options by funds: $15.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$132M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$99.6M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$76.1M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$54.6M |
| 5 |
TFM
Trian Fund Management
New York
|
+$51.1M |
Top Sellers
CC Hedge Fund Activity: Q3 2015 in Review
460 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2015, worth a combined $846M.
Buyers outnumbered sellers: 460 funds opened new CC positions and 0 closed out — a net gain of 460 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $132M.
- 460 institutional investors held Chemours (CC) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $846M of Chemours stock for Q3 2015.
- 460 funds opened new Chemours positions in Q3 2015 and 0 closed out, a net change of +460 holders.
- The largest Chemours buyer in Q3 2015 was Vanguard Group, an estimated $132M added.
Based on aggregated 13F filings for Q3 2015.